DEPO-SUBQ PROVERA 104® Description
(medroxyprogesterone acetate)
11 DESCRIPTION
Depo-subQ provera 104 contains medroxyprogesterone acetate (MPA), a derivative of progesterone, as its active ingredient. MPA is a white to off-white, odorless crystalline powder that is stable in air and that melts between 205°C and 209°C. It is freely soluble in chloroform, soluble in acetone and dioxane, sparingly soluble in alcohol and methanol, slightly soluble in ether, and insoluble in water.
The chemical name for MPA is 17-hydroxy-6α-methylpregn-4-ene-3,20-dione 17-acetate. The structural formula is as follows:
Depo-subQ provera 104 for subcutaneous use is available in pre-filled syringes, each containing 0.65 mL (104 mg) of sterile medroxyprogesterone acetate injectable suspension.
Each 0.65 mL contains the following inactive ingredients:
Methylparaben | 1.040 mg |
Propylparaben | 0.098 mg |
Sodium Chloride | 5.200 mg |
Polyethylene Glycol | 18.688 mg |
Polysorbate 80 | 1.950 mg |
Monobasic Sodium Phosphate H2O | 0.451 mg |
Dibasic Sodium Phosphate 12H2O | 0.382 mg |
Methionine | 0.975 mg |
Povidone | 3.250 mg |
Water for Injection | qs |
When necessary, the pH is adjusted with sodium hydroxide or hydrochloric acid, or both.
Find DEPO-SUBQ PROVERA 104® medical information:
Find DEPO-SUBQ PROVERA 104® medical information:
DEPO-SUBQ PROVERA 104® Quick Finder
Health Professional Information
Description
11 DESCRIPTION
Depo-subQ provera 104 contains medroxyprogesterone acetate (MPA), a derivative of progesterone, as its active ingredient. MPA is a white to off-white, odorless crystalline powder that is stable in air and that melts between 205°C and 209°C. It is freely soluble in chloroform, soluble in acetone and dioxane, sparingly soluble in alcohol and methanol, slightly soluble in ether, and insoluble in water.
The chemical name for MPA is 17-hydroxy-6α-methylpregn-4-ene-3,20-dione 17-acetate. The structural formula is as follows:
Depo-subQ provera 104 for subcutaneous use is available in pre-filled syringes, each containing 0.65 mL (104 mg) of sterile medroxyprogesterone acetate injectable suspension.
Each 0.65 mL contains the following inactive ingredients:
Methylparaben | 1.040 mg |
Propylparaben | 0.098 mg |
Sodium Chloride | 5.200 mg |
Polyethylene Glycol | 18.688 mg |
Polysorbate 80 | 1.950 mg |
Monobasic Sodium Phosphate H2O | 0.451 mg |
Dibasic Sodium Phosphate 12H2O | 0.382 mg |
Methionine | 0.975 mg |
Povidone | 3.250 mg |
Water for Injection | qs |
When necessary, the pH is adjusted with sodium hydroxide or hydrochloric acid, or both.
Health Professional Information
{{section_name_patient}}
{{section_body_html_patient}}
Resources
Didn’t find what you were looking for? Contact us.
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Report Adverse Event
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.